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Embryonic stem cells have a pluripotency and a potential
to differentiate to all type of cells. In our previous study, we
have shown that embryonic stem cells (ESCs) lines can be
generated from murine parthenogenetic embryos. This
parthenogenetic ESCs line can be a useful stem cell source
for tissue repair and regeneration. The defect in full-term
development of parthenogenetic ESCs line enables
researchers to avoid the ethical concerns related with ESCs
research. In this study, we presented the results demon-
strating that parthenogenetic ESCs can be induced into
osteogenic cells by supplementing culture media with
ascorbic acid and ß-glycerophosphate. These cells showed
morphologies of osteogenic cells and it was proven by Von
Kossa staining and Alizarin Red staining. Expression of
marker genes for osteogenic cells (osteopontin, osteonectin,
alkaline phosphatase, osteocalcin, bone-sialoprotein, collagen
type1, and Cbfa1) also confirmed osteogenic potential of
these cells. These results demonstrate that osteogenic cells
can be generated from parthenogenetic ESCs in vitro.
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Introduction
In dentistry, adequate development of cranium and the
quality of maxillary or mandibular alveolar bone is crucial
for maintaining normal dentition. Especially with the rise of
dental implant prosthesis of recent decades, the importance
of dental alveolar bone has been rising. The extent and level
of osseointegration of implant fixture to dental alveolar
bone is decisive factor for the ‘primary fixation’, which is
considered as the success criteria for implant surgery
(Szmukler-Moncler et al, 2000). Thus, nowadays skeletal
repair has been great issue in medical and dental clinic.
Many of the current strategies to repair skeletal damage
include the use of autogenous or allogenic bone grafts as
well as various prosthetic implant devices (Damien et al.,
1991; Crane et al., 1995). However, these approaches has
many insufficiencies including availability of suitable bone
graft material, and also issues of biocompatibility and
failure of implant prostheses have created the need to
develop alternative strategies (Buttery et al., 2001). In this
regard, regenerative skeletal repair using molecular and
cellular regulation has been great issue in medical and
dental clinic. 
An important consideration for regenerative tissue repair
is the ability to generate appropriate type of cells with
sufficient numbers (Langer et al., 1993; Minuth et al., 1998;
Caplan et al., 2000). In this regard, the ESCs lie in the center
of attention in clinical osteogenic-regenerative study as it
has pluripotency which means that potential to differentiate
into all fetal cell types. However, it is difficult to induce
differentiation into intended cell type, and also application
potential of ESCs to cell therapy has the limits caused by
immune rejection responses (Bradley et al, 2002). To avoid
these problems, it may be useful to use tissues having the
patients' own genetic information. In this regard, adult
mesenchymal stem cells (MSCs) research came to an
interest. MSCs, isolated from bone marrow aspirates, have
been used to facilitate bone repair in various osseous defect
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models (Jaiswal et al., 1997; Ohgushi et al., 1989; Caplan et
al, 1997; Cummine et al., 1983). 
As MSCs has multipotency with patients' own genetic
information, these cells can deal with several problems
related to tissue repair. However, MSCs has some
limitations on clinical usage. These cells have relatively low
frequency of occur in the marrow stroma, with perhaps as
few as 1 in 100,000 cells being a true stem cell (Quarto et al.,
1995; D'Ippolito et al., 1999). They also have a finite
capacity for self-renewal (McCulloch et al., 1991), and with
increasing age, both the potential to differentiate to specific
cell type is diminished (Bourne et al., 2004). 
Parthenogenetic ESCs is able to complement with these
problems and be the alternative cell source for skeletal tissue
engineering. Parthenogenetic ESCs has pluripotency as well
as patient's own genetic information if the cells are
originated from the oocytes from the same patient. Women
are more susceptible to osteoporosis and other osteo-
diseases, thus researches using the blastocyst and ESCs
derived from patient's own oocytes are coming into a great
issue. We have shown that ESCs lines can be generated from
mouse parthenogenetic embryos (Choi et al., 2006). In the
present study, we demonstrated successful in vitro
differentiation of murine parthenogenetic ESCs toward
osteogenic lineages. The osteogenic differentiation was
verified by Von Kossa and Alizarin red staining. Evidence
of the existing differentiated cell population after osteogenic
induction was analyzed by RT-PCR, which confirmed the
expression of osteogenic-specific genes-osteopontin, osteo-
nectin, alkaline phosphatase, osteocalcin, bone-sialo-
protein, collagen type1, and Cbfa1. Bone-sialoprotein,
osteocalcin and Cbfa1 were used as intermediate/late
osteogenic markers, while the others were used as early/
intermediate ones (Zur Nieden et al., 2007).
Materials and Methods
Chemicals
All inorganic and organic compounds were obtained from
Sigma-Aldrich Korea (Yong-in, Korea) unless otherwise
stated. All media used were based on CZB and KSOM
(Nagy et al., 2003).
Recovery of oocytes
Eight-week-old C57BL6 X DBA2 F1-hybrid mice were
superovulated by intraperitoneal injections of 7.5 IU eCG
and 7.5 IU hCG, given 48 h apart. Oocytes were recovered
16 h after hCG injection, and the oviducts were removed
and transferred into a Petri dish containing 2 ml Hepes-
buffered CZB medium (HCZB), supplemented with 300 IU/
ml hyaluronidase. The oviduct ampullae were opened and
the cumulus-enclosed oocytes were released. After 2 to 3
min exposure to the medium, the cumulus-free oocytes were
washed twice in HCZB before activation. 
Activation and in vitro culture
Recovered oocytes were immediately exposed to an
activation medium, consisting of 10 mM SrCl2 with 5 µg/ml
cytochalasin B in calcium-free CZB for 5 h, and then
cultured for 115 h in KSOM at 37
o
C in a humidified 5% CO2
in air. After in vitro culture, zona pellucida of the blastocysts
were removed by washing the embryos with acid-Tyrode
solution.
Establishment of embryonic stem cell lines from
parthenogenetic murine embryos
To generate ESC, thirty to fifty zona-free blastocysts were
transferred onto STO feeder layer in gelatinized tissue
culture plates (Nunc, Roskilde, Denmark) in ESC medium
consisting of Dulbecco’s modified Eagle’s medium
(DMEM; Life Technologies, Paisley, UK) supplemented
with 15% fetal bovine serum (FBS), 1% nonessential amino
acid (NEAA), 0.1 mM β-mercaptoethanol and 1,000 units/
ml ESGRO leukemia inhibitory factor (LIF; Chemicon,
Temecula, USA). After 6 or 7 day of culture, the outgrown
clumps derived from the ICM were counted under the
stereo-microscope. Once the ICM outgrowth was evaluated,
the cell clumps were further trypsinized with 0.05% trypsin-
EDTA and seeded onto gelatinized new 4-well dish with
fresh ES medium in order to generate parthenogenetic ESC.
When the colonies appeared, they were considered as
passage 0 and had been propagated gradually under the
stringent culture conditions with careful monitoring and
medium change to keep undifferentiated state and to avoid
their differentiation.
Culture of Parthenogenetic ESCs 
The parthenogenetic murine ESCs were cultivated on a
feeder layer of mitomycin C-treated STO cells maintained
in DMEM. And the medium was supplemented with 10%
(v/v) FBS, 2mM L-glutamine, 0.1 mM β-mercaptoethanol,
50 U/ml penicillin, and 50 mg/ml streptomycin. Culture
medium was also supplemented with leukemia inhibitory
factor (LIF, 1,000 IU/ml), and maintained at 37
o
C, 5% CO2,
and changed once per day.
Embryoid body (EB) formation
To make EB, ESCs on the culture plates were lightly
trypsinized for 2 min at 37
o
C. Trypsinization was termi-
nated by addition of DMEM containing 10% fetal bovine
serum (FBS). After brief centrifugation, cells were re-
suspended in medium followed by medium supplemen-
tation with 10% (v/v) FBS, 2 mM L-glutamine, 0.1 mM â-
mercaptoethanol, 50 U/ml penicillin, 50 mg/mL strepto-
mycin and 10
−7
M retinoic acid. Cells were plated onto
bacteriological grade petri-dishes in the absence of
fibroblast feeder layers and LIF. ESCs were maintained for
5 days in culture, with medium being replenished on day 3.
After 5 days in culture, ESCs formed free-floating aggre-
gates or EB. 
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Osteogenic induction of EBs
Osteogenic induction protocol was modified from the
method of Buttery et al (2001). Briefly, The EBs were
resuspended in alpha-modified Eagle’s medium (a-MEM)
containing 10% FBS, 50 U/ml penicillin, and 50 mg/ml
streptomycin and allowed to adhere to six-well culture
plates at a density of three EB/well. In cultures, medium was
additionally supplemented with 50 mg/ml ascorbic acid and
10 mM β-glycerophosphate. The EBs were maintained in
culture for 21 days and medium was replaced every 3 days. 
Cell staining
For Von Kossa staining, the culture plates were rinsed off in
PBS for twice and then fixed for 30 min in 70% ethanol. After
being washed twice with double distilled water (DDW), 5%
silver nitrate solution (60 watt lamp/UV for 20 min) was added
until calcium turned black followed by three times of rinsing
with DDW. Nuclear fast red were applied for 5 min to the cells. 
Alizarin red staining of mineralized colonies was started
with rinsing off culture plates with PBS for twice. The cells
were then fixed with 0.2% glutaraldehyde for 5 min and
washed off three times with DDW then 1% Alizarin Red S
solution was applied for 10 min onto the cell culture plates.
Excessive staining materials were washed off with DDW
and the plates were then air dried (Bielby et al., 2004).
RT-PCR analysis 
RNA extract of ostegenic cells derived from partheno-
genetic ESCs was prepared. The cells were lysed with 1 ml
of TRI reagent, and the lysate was homogenized by
repetitive pipetting. These cell homogenate was transferred
to a new tube and stored for 5-15 min at room temperature.
Then 0.2 ml of chlorform was added per 1 ml of TRI agent.
After vortexing for 15 s, the homogenate was stored at room
temperature until aqueous layers were appeared. After
centrifugation at 4
o
C, upper colorless aqueous phase con-
taining RNAs and lower phenol-chloroform phase and
interphase that contains DNA with protein were separated.
Then aqueous phase were transferred into a new tube for
isolation of RNAs and kept at −70
o
C. RNAs from partheno-
genetic ESCs cells were used as the control group. As next,
each RNA extract was carried out reverse transcription
reaction. After the reverse transcription reaction, the final
volume was increased to 50 ìl with ultra-purified water and
then stored at −20
o
C until RT-PCR analysis. The analyses
were performed in a final volume of 50 µl. The reactions
contained 1 µl of the cDNA sample, 2 mM MgCl2, 50 mM
KCl, 10 mM Tris- HCI (pH 8.3), 2.5 mM of each dNTP, 20
ìM of each primer (Table 1), and 1 ìl of rTaq polymerase
(TaKaRa Korea, Seoul, Korea). After a first denaturation step
of 5 min at 94
o
C, 35 amplification cycles were performed.
Each cycle involved denaturation at 94
o
C for 40 s, annealing
at 55
o
C for 40 s, and extension at 72
o
C for 40 sec. A final
extension step of 7 min at 72
o
C was performed to complete
the PCR. The PCR product was electrophoresed on a 1%
agarose gel, stained with ethidium bromide, and visualized




Bone sialoprotein 5’-CAGAGGAGGCAAGCGTCACT-3’ 5’-CTGTCTGGGTGCCAACACTG-3’
Osteopontin 5’-GATGCCACAGATGAGGACCT-3’ 5’-CTGGGCAACAGGGATGACAT-3’
Collagen type I 5’-GCATGGCCAAGAAGACATCC-3’ 5’-CCTCGGGTTTCCACGTCTC-3’
Alkaline phosphatase 5’-GTGCCCTGACTGAGGCTGTC-3’ 5’-GGATCATCGTGTCCTGCTCAC-3’
Cbfa1 5’-GTGCGGTGCAAACTTTCTCC-3’ 5’-AATGACTCGGTTGGTCTCGG-3’
Fig. 1. The morphology of colonies formed after osteogenic induction of parthenogenetic embryonic stem cells was monitored and photo-
graphed. (A) The cells displays distinctive morphology of osteogenic cells. (B) Alizarin Red staining: Calcium turns out to be orange-red. The
end product of Alizarin red staining is an Alizarin Red-calcium complex. It demonstrated the existence of calcium content in tissue sections
which is the characteristic of the calcified osteoblasts. (C) Von Kossa staining: Nuclei appear to be red, cytoplasm as pink, and calcium depo-
sition turns out to be black. Scale bar: A- 1 mm, B and C- 2.5 mm.
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Animal ethics
All animal experiments were approved and performed
under the guidelines of the Institutional Animal Care and
Use Committee of Seoul National University.
Results
Morphological and histochemical characteristics
The morphology of colonies formed in the cells after
osteogenic induction was checked and photographed. The
differentiated parthenogenetic ESCs displayed distinctive
morphology of osteogenic cells (Fig. 1A), and histo-
chemical characteristics were verified by Alizarin Red and
Von Kossa staining (Fig. 1B and C, respectively). In
Alizarin Red staining, calcium turns out to be orange-red. In
Von Kossa staining, nuclei appear to be red, cytoplasm as
pink, and calcium deposition turns out to be black.
RT-PCR analysis 
The genes of osteopontin, osteocalcin, osteonectin, bone-
sialoprotein, collagen type1, Cbfa1 and alkaline phos-
phatase were strongly expressed in the osteogenic cells
differentiated from parthenogenetic ESCs while only
alkaline phosphatase and collagen type1 genes were
expressed in the undifferentiated parthenogenetic ESCs.
The expression of intermediate/late osteogenesis markers of
Cbfa1, bone-sialoprotein and osteocalcin means that fully
differentiated osteogenic cell population, not progenitors,
existed in the experimental group.
Discussion
In this study, we presented in vitro data demonstrating that
mouse parthenogenetic ESCs can differentiate into
osteogenic cells lineage. Von Kossa staining and Alizarin
red staining have confirmed calcium deposition in the
differentiated cells. Basically, bone is a mineralized
connective tissue consisting of mainly type I collagen and
other non-collageneous matrix proteins, such as bone
sialoprotein, osteocalcin, osteonectin, osteopontin, and
proteoglycans that determine characteristics of osteoblasts
(Nanci, 2003). Osteopontin, a non-collagenous bone matrix
molecule, is associated with osteoblastic cell adhesion and
abundantly expressed during the early stages of osteoblast
differentiation (Bourne et al., 2004), was expressed in the
parthenogenetic ESCs in our study. The expression of
intermediate/late osteogenesis markers such as Cbfa1,
bone-sialoprotein and osteocalcin also showed existence of
fully differentiated osteogenic cell population as well as
osteogenic progenitors. These results strongly suggest that
osteogenic induction of parthenogenetic ESCs was driven
into the osteogenic lineage, which might be an alternative
embryonic stem cell source for the study of skeletal repair
and regeneration. Especially the defects in full-term
development of this cell lines have ability to enablere-
searchers to avoid the ethical concerns related embryonic
stem cell research. Although there are many remarkable
researches on tissue engineering and regenerative medicine
using cellular supports (Daar et al., 2007; Freymana et al., 2001),
few of those are related on hard tissue regeneration using
parthenogenetic ESCs and their derivatives. Although
osteogenic differentiation of normal murine ESC was once
reported (Buttery et al., 2001), studies on parthenogenetic
ESCs focused on the histocompatibility of ESCs and their
potential of non-specific three-germ layer differentiation
after EB induction (Kim et al., 2006; Lengerke et al., 2007).
Integrity of alveolar bone affects significantly on
successful osseointegration and primary fixation of dental
implant fixture, thus it plays crucial part on success of dental
implant prosthesis (Hujaa et al., 2004; Smith et al., 1989). If the
osteogenic cells generated from parthenogenetic ESCs could
enhance bone regeneration, it will help alveolar socket healing
of female patients with regenerative problems, and can help
edentulous people to recover anatomic integrity of alveolar
ridge that would enable them to get the retentions for full arch
Fig. 2. Comparison of gene expression between the osteogenic
cells derived from parthenogenetic embryonic stem cells (OSP,
Left), and undifferentiated parthenogenetic embryonic stem cells
(PESC, Right) was performed by RT-PCR. 1. osteopontin, 2.
osteonectin, 3. alkaline phosphatase, 4. osteocalcin, 5. bone-sialo-
protein, 6. collagen type1, 7. Cbfa1. All osteogenic marker genes
were expressed in OSP whereas only alkaline phosphatase and col-
lagen type1 genes were expressed in PESC.
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denture prosthetics, and enhance primary osseointegration of
implant fixture to dental alveolar bone as well as less concern
about histocompatibility. This kind of cell therapy can also help
female patients of innate malformations and defects, and
patients under oromaxillo-facial cancer therapy. Further in vivo
studies are needed to confirm the hard tissue regeneration
potential of parthnogenetic ESC derivatives.
In summary, we demonstrated that parthenogenetic ESCs can
be generated into osteogeneic lineage by supplementing
defined inducing factors to culture medium. It may enable
researchers to avoid the ethical concerns related with ESCs
researches. As demands on regenerative medicine and
dentistry related to bone disease and defects are increasing,
approaches using parthenogenetic ESCs could be one of the
alternative solutions for the hard tissue regeneration and
skeletal tissue repair.
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